​

​

Regulatory Approval 

Our Clinical TES systems are approved by the Australian Government's Therapeutic Goods Administration (TGA)  ARTG Entry: 284637

​

​

Clinical Systems

Soterix Medical is committed to provide patients and physicians the most advanced, user-friendly, and effective neuromodulation treatments. Our clinical tDCS platforms are the only system to incorporate the latest, most robust technology. Unique electrode and head-gear snap-in technology make consistent and comfortable stimulation “a snap” for patient and care-givers.

​

Explore How The Depression tDCS-LTE™ System Works...

​

Explore How The PainX™ tDCS System Works...​

​

​

What tDCS?

Transcranial Direct Current Stimulation (tDCS) is a non-invasive procedure in which a device sends a small Direct Current (DC) across the scalp to modulate brain function. 

tDCS mechanisms are considered to result from the ability of very weak DC currents to safely induce reversible changes in cortical plasticity. The induction of lasting changes in cortical excitability can, under some conditions, reversibly modify behavior and interact with normal learning. Such findings have driven a large number of studies examining whether tDCS might induce functionally significant changes in patients with a large variety of neurological and psychiatric disorders.

​

Evidence based:

 

• Delivering Transcranial Direct Current Stimulation Away From Clinic: Remotely Supervised tDCS.  Shaw M, Pilloni G, Charvet LE. doi: 10.1093. PubMed PMID: 32074357. (2020)

• Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression. Brunoni A.R., Moffa A.H., Sampaio-Junior B., Borrione L., Moreno M.L., Fernandes R.A., Veronezi B.P., Nogueira B.S., Aparicio L.V.M., Razza L.B., Chamorro R., Tort L.C., Fraguas R., Lotufo P.A., Gattaz W.F., Fregni F., Benseñor I.M.; ELECT-TDCS Investigators. (2017)

• Transcranial direct current stimulation for the treatment of post-stroke depression: results from a randomised, sham-controlled, double-blinded trial. Valiengo L.C., Goulart A.C., de Oliveira J.F., Benseñor I.M., Lotufo P.A., Brunoni A.R. (2017)

• Safety of Transcranial Direct Current Stimulation: Evidence Based Update Bikson M, Grossman P, Thomas C, Zannou AL, Jiang J, Adnan T, Mourdoukoutas AP, Kronberg G, Truong D, Boggio P, Brunoni AR, Charvet LE, et al. Brain Stimul. PubMed PMID: 27372845 (2016)

• Concurrent cognitive control training augments the antidepressant efficacy of tDCS: a pilot study. Segrave R.A., Arnold S., Hoy K., Fitzgerald P.B. (2014)

• The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. Brunoni, A.R, Valiengo L., Baccaro A., Zanao T.A., de Oliveira J.F., Goulart A., Boggio P.S., Lotufo P.A., Bensenor I.M., Fregni,F. (2013)

• Transcranial direct current stimulation for depression: 3-week, randomized, sham-controlled trial. Loo C.K., Alonzo A., Martin D., Mitchell P.B., Galvez V., Sachdev P. (2012)

• A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Boggio P.S., Rigonatti S.P., Riberiro R.B., Myczkowski M.L., Nitsche M.A., Pascual-Leone A., Fregni F.(2008)

​

​